
CRDN supports the WHA Resolution on Rare Diseases
CRDN proudly supports the WHA Resolution on Rare Diseases, aligning with our mission to advance care, research, and health equity for Canada’s rare disease community through global collaboration.
News related to rare disease, including patient stories, new programs and initiatives, and more.

CRDN proudly supports the WHA Resolution on Rare Diseases, aligning with our mission to advance care, research, and health equity for Canada’s rare disease community through global collaboration.

CRDN invites the rare disease community to take part in a survey to share feedback on our draft strategic plan, helping us ensure it meets the needs of the entire community.

The Patient and Community Engagement Research (PaCER) program is launching its January 2025 cohort, focusing on how rare diseases impact families. This unique, fully sponsored opportunity invites parents from across Canada to collaborate and share their experiences.

CRDN, alongside MICYRN and RareKids-CAN, will support the newly launched European Rare Diseases Research Alliance (EDERA), ensuring that Canada’s rare disease landscape is aligned with international efforts.

CRDN participated in a two-day Alberta Rare Disease (RD) Design Framework workshop to develop recommendations to help guide the creation of a comprehensive care framework in Alberta.
CRDN participated in annual NMD4C investigator meeting to share insights and explore synergistic efforts in the innovative therapy space in Canada.
Stay updated with the latest developments and events from the CRDN as we advance rare disease research and care across Canada.

Dr. François Bernier and Dr. Catherine Strandt attended the 2026 ERDERA General Assembly in Portugal to learn about ongoing initiatives and explore opportunities to advance international rare disease research collaboration.

CRDN celebrates continued federal funding for Canada’s rare disease drug strategy and highlights the importance of connecting treatment access with timely diagnosis, coordinated care, and research.

Natasha Trehan, a 2026 RAREvolution Scholar, reflects on life beyond diagnosis and treatment as CRDN builds opportunities for peer connection, mentorship, and engagement through its inaugural scholarship program.

Five parent caregivers from across Canada have completed a year-long research training program, bringing their lived experience to a study exploring strength, support, and well-being among families affected by rare diseases.

CRDN’s third Open Access Government article explores why Canada must invest in the people, expertise, and clinical systems needed to turn genomic advances into timely and equitable rare disease diagnosis.

CRDN was pleased to attend the 2026 NMD4C Annual Meeting in Calgary, bringing together members of the neuromuscular disease community for a full day of research updates, strategic discussions, collaboration, and connection.